Title: Safety and proof of principle study of ATX-GC-59 in male and female subjects with Graves' disease not currently treated with anti-thyroid therapy: An open label study with an upward titration over 5 dose levels administered by intradermal injection

Funder
Cardiff & Vale University Health Board

Principal Investigator

Project Details
Net value award figure for Cardiff University: £25,462.00
Start date: 01/08/2016
End date: 31/03/2020

Last updated on 2020-20-09 at 06:02